Biotechnology
GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a Phase I/II Clinical Trial Treating Advanced Solid Tumor Patients with KRAS G12D Mutation
SHANGHAI, June 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announcedChina's National Medical Products Administration (NMPA) has approved the clinical trial application for GFH375 (VS-7375) in...
2024-06-19 19:00
1905
Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report
Emerging standouts set to transform drug discovery and development, revolutionize cancer treatment, and capture big pharma interest highlighted in third annual report LONDON, June 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has re...
2024-06-19 15:00
1570
Tang Prize in Biopharmaceutical Science Honoring Three Scientists
TAIPEI, June 19, 2024 /PRNewswire/ -- In a continuing series of laureate announcements, the Tang Prize Foundationtoday (June 19th) announced the 2024 Tang Prize in Biopharmaceutical Science recipients. The prestigious award has been jointly awarded toJoel F. Habener, Svetlana Mojsov, and Jens Juu...
2024-06-19 12:15
1523
Innovent Reports Oncology Pipeline Updates at Investor Meeting
SAN FRANCISCO and SUZHOU, China, June 19, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and o...
2024-06-19 10:55
4322
YolTech and KACTUS Join Forces to Propel Innovative DNA editing system in Greater China
Strategic Partnership to Advance Gene Editing Technologies in Biomedical Applications SHANGHAI, June 18, 2024 /PRNewswire/ -- YolTech, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery forin vivo gene editing therapies, has partnered with KACTUS, a leading developer se...
2024-06-19 09:00
1611
Bloomage Leads Discussions of Hyaluronic Acid Development at 2nd Hyaluronic Acid Industry Conference
PARSIPPANY, N.J., June 18, 2024 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and bioactive substance innovations, presented at the 2nd Hyaluronic Acid Industry Conference, a premier healthcare knowledge base and network platform. At the event, Bloomage led discussions to undersco...
2024-06-18 22:00
1340
Singleron Biotechnologies partners with the Human Cell Atlas (HCA) to enhance access to single cell analysis globally
COLOGNE, Germany, June 18, 2024 /PRNewswire/ -- Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate the adoption of single cell sequencing globally. Singleron will facilitate access to its single cell analysis platform via the HCA network, by provi...
2024-06-18 21:00
1866
Prenetics Announces First Quarter 2024 Financial Results
First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S. Consumer Healthcare Market Reaffirms 2024 Revenue Range of US$33 million to US$36 million LOS ANGELES, June 18, 2024 /PRNewswire/ -- Prenetics Global Limit...
2024-06-18 20:30
4013
Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults
-- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralizing antibody titers in older adults up to approximately 7,900 IU/mL (up to 8-fold increase) and approximately 46,700 IU/mL (up to 11-fold increase), respectively -- -- Favorable safety & reactogenicity profile comparable to sali...
2024-06-18 17:41
2211
Thermo Fisher Scientific, National University Hospital and Mirxes Collaborate to Enhance Access to Advanced Genomic Testing for Early Cancer Detection in Singapore
Partnership Aims to Personalize Cancer Care Tailored to the Needs of Southeast Asian Population to Provide Better Individualized Care SINGAPORE, June 18, 2024 /PRNewswire/ -- To increase patient access to affordable, advanced genomic testing for cancer inSingapore, Thermo Fisher Scientific Inc.,...
2024-06-18 16:46
5852
Live from EHA 2024 | Ascentage Pharma Releases Updated Data of Lisaftoclax in Patients with R/R MM and AL Amyloidosis Highlighting Marked Improvement in ORR
SUZHOU, China and ROCKVILLE, Md., June 18, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data of the Bcl-2 inh...
2024-06-18 12:43
2164
Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including Encouraging Data from US Study in CML and Ph+ ALL
SUZHOU, China and ROCKVILLE, Md., June 18, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that updated results from three studies of olverem...
2024-06-18 12:23
1961
Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions
* A phase 1b/2a trial evaluated once- and bi-weekly GZR18, a novel GLP-1 analog, in Chinese subjects with obesity/overweight * Pre-clinical studies evaluated the molecular and pharmacological properties of GZR4, an investigational once-weekly insulin analog * Pre-clinical studies evaluated ...
2024-06-18 12:13
2314
Leading the Digital Revolution for Health: European Wellness and QBeep Launches Groundbreaking "SmartMFDealers" App
KOTA KINABALU, Malaysia, June 18, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG) and QBeep Intelligent Systems Sdn Bhd (QBeep) have officially launched their game-changing "SmartMFDealers" (SMFD) mobile application – a partnership set to mark a new chapter in delivering quality h...
2024-06-18 08:00
1945
ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals
BRISBANE, Calif. and SHANGHAI, June 17, 2024 /PRNewswire/ -- ReviR Therapeutics, a biotechnology company specializing in the development of small molecule RNA splicing modulators for neurogenetic diseases and oncology indications, and Asieris Pharmaceuticals, a global biopharmaceutical leader in ...
2024-06-17 22:00
1897
Noul Participates in a Malaria Project Initiated by U.S. CDC with Kenya Medical Research Institute
* Gain attention as an alternative technology to the malaria HRP-2/3 gene deletion problem inAfrica * Prepare a bridgehead to enter the U.S. market by securing a credible reference YONGIN, South Korea, June 17, 2024 /PRNewswire/ -- On-Device AI healthcare company, Noul, announced that it will...
2024-06-17 21:00
1926
Peijia Medical Reports Audited 2023 Financial Results and Resumes Trading
HONG KONG, June 17, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets, announced the publication of its audited financial results for the year endedDecember...
2024-06-17 20:30
2991
Chinese Team Secures "Best Showpiece Award" at the 52nd UIBC International Competition for Young Bakers with Angel Yeast's Support
REYKJAVIK, Iceland, June 17, 2024 /PRNewswire/ -- In a recent display of global baking talent, the 52nd UIBC International Competition for Young Bakers took place inReykjavik, Iceland, featuring 14 contestants from 7 nations. As the sole Asian representative, the Chinese team made a remarkable im...
2024-06-17 15:17
9276
ISTH 2024 Unveils Late-Breakthrough Abstracts to be Presented in Bangkok, Thailand Showcasing Groundbreaking Science and Research
International scientific meeting convenes in Bangkok, Thailand, for the first time highlighting the important work of the Asian-Pacific scientific and clinical community BANGKOK, June 17, 2024 /PRNewswire/ -- Today, the International Society on Thrombosis and Haemostasis (ISTH) announces that al...
2024-06-17 10:00
1820
IASO Bio Presented New Data of FUCASO® (Equecabtagene Autoleucel) for the Treatment of High-risk Newly Diagnosed Multiple Myeloma in Oral Presentation at EHA 2024
SHANGHAI and NANJING, China and SAN JOSE, Calif., June 15, 2024 /PRNewswire/ -- IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented clinical data on the use of Equec...
2024-06-15 22:30
3830
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5209
